logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 2
  • 1
    Sobol, Richard Ernest
    Born in December 1967
    Individual (34 offsprings)
    Officer
    2016-02-12 ~ now
    OF - Director → CIF 0
    Mr Richard Ernest Sobol
    Born in December 1967
    Individual (34 offsprings)
    Person with significant control
    2017-02-12 ~ now
    PE - Right to appoint or remove directorsCIF 0
  • 2
    JARELL LIMITED
    09512613 06546700
    10th Floor, 60 Church Street, Birmingham, West Midlands, England
    Active Corporate (1 parent, 8 offsprings)
    Person with significant control
    2017-02-12 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

CAPITAL PHARMA LIMITED

Period: 2016-02-12 ~ now
Company number: 10001725
Registered name
CAPITAL PHARMA LIMITED - now
Standard Industrial Classification
78200 - Temporary Employment Agency Activities
Brief company account
Average Number of Employees
02024-03-01 ~ 2025-02-28
02023-03-01 ~ 2024-02-29
Debtors
1,000 GBP2025-02-28
1,017 GBP2024-02-29
Cash at bank and in hand
256 GBP2025-02-28
571 GBP2024-02-29
Current Assets
1,256 GBP2025-02-28
1,588 GBP2024-02-29
Creditors
Current
179,028 GBP2025-02-28
171,503 GBP2024-02-29
Net Current Assets/Liabilities
-177,772 GBP2025-02-28
-169,915 GBP2024-02-29
Total Assets Less Current Liabilities
-177,772 GBP2025-02-28
-169,915 GBP2024-02-29
Creditors
Non-current
25,009 GBP2025-02-28
30,519 GBP2024-02-29
Net Assets/Liabilities
-202,781 GBP2025-02-28
-200,434 GBP2024-02-29
Equity
Called up share capital
1,000 GBP2025-02-28
1,000 GBP2024-02-29
Retained earnings (accumulated losses)
-203,781 GBP2025-02-28
-201,434 GBP2024-02-29
Equity
-202,781 GBP2025-02-28
-200,434 GBP2024-02-29
Property, Plant & Equipment - Gross Cost
Plant and equipment
3,550 GBP2024-02-29
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
3,550 GBP2024-02-29
Other Debtors
Current, Amounts falling due within one year
1,000 GBP2025-02-28
Amounts falling due within one year, Current
1,017 GBP2024-02-29
Bank Borrowings/Overdrafts
Current
5,511 GBP2025-02-28
5,374 GBP2024-02-29
Trade Creditors/Trade Payables
Current
87 GBP2025-02-28
479 GBP2024-02-29
Amounts owed to group undertakings
Current
170,415 GBP2025-02-28
162,414 GBP2024-02-29
Other Taxation & Social Security Payable
Current
190 GBP2025-02-28
181 GBP2024-02-29
Other Creditors
Current
2,825 GBP2025-02-28
3,055 GBP2024-02-29
Bank Borrowings/Overdrafts
Non-current
25,009 GBP2025-02-28
30,519 GBP2024-02-29

  • CAPITAL PHARMA LIMITED
    Info
    Registered number 10001725
    10th Floor 60 Church Street, Birmingham, West Midlands B3 2DJ
    PRIVATE LIMITED COMPANY incorporated on 2016-02-12 (10 years 2 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-02-12
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 5 April 2026 and licensed under the Open Government Licence v3.0.